Evanson Jeff (CIK 0001760511)

Latest company ownership

OTLK - Outlook Therapeutics, Inc.

Role: CHIEF COMMERCIAL OFFICER

Shares held

25,000

Last filed at

Mar 22, 2024

Confidence Score

50.0

2025Q4

Confidence Score History

2021Q1 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Mar 7, 2024	Mar 11, 2024	Outlook Therapeutics, Inc.	CHIEF COMMERCIAL OFFICER	Buy	86.3	+62,484	8.38%	✗	$26.2K
Jan 20, 2023	Jan 24, 2023	Outlook Therapeutics, Inc.	Chief Commercial Officer	Sell	20.0	-267,000	-26.36%	✗	$296.4K
Jan 17, 2023	Jan 19, 2023	Outlook Therapeutics, Inc.	Chief Commercial Officer	Sell	22.5	-164,155	-13.95%	✗	$203.7K
Dec 3, 2021	Dec 6, 2021	Outlook Therapeutics, Inc.	Chief Commercial Officer	Buy	83.8	+35,200	3.08%	✗	$47.2K
Feb 23, 2021	Feb 25, 2021	Outlook Therapeutics, Inc.	Chief Commercial Officer	Sell	36.3	-8,554	-0.74%	✗	$17.9K
Feb 12, 2021	Feb 17, 2021	Outlook Therapeutics, Inc.	Chief Commercial Officer	Sell	22.5	-56,973	-4.72%	✗	$145.3K